Outer membrane protein (OMP) based vaccine for serogroup B

References

Page 1

	Year	Citations
Vaccination against <i>Neisseria meningitidis</i> Using Three Variants of the Lipoprotein GNA1870 Vega Masignani, Maurizio Comanducci, Marzia Monica Giuliani, The Journal of Experimental Medicine New VaccineImmunologyLipoprotein Gna1870Medical MicrobiologyReverse Vaccinology	2003	397
Vaccine Potential of the<i>Neisseria meningitidis</i>2086 Lipoprotein Leah Fletcher, Liesel Bernfield, Vicki Barniak, Infection and Immunity Pathogen DetectionKlebsiella PneumoniaeImmunologyPathologyIncluded Isolates	2004	333
Structural and Evolutionary Inference from Molecular Variation in <i>Neisseria</i> Porins Jeremy P. Derrick, Rachel Urwin, Janet Suker, Infection and Immunity Microbial PathogensMolecular BiologyMolecular VariationBacterial PathogensMicrobial Evolution	1999	141
Distribution of Neisseria meningitidisSerogroup B Serosubtypes and Serotypes Circulating in the United States M. Lucia Tondella, Tanja Popović, Nancy E. Rosenstein, Journal of Clinical Microbiology	2000	115
Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a <i>Neisseria meningitidis</i> Candidate Vaccine Jo Anne Welsch, Raffaella Rossi, Maurizio Comanducci, The Journal of Immunology VaccinationVaccine DevelopmentGenome-derived Neisserial AgMurine Igg MabsVaccine Target	2004	114
Cross-Reactivity of Antibodies against PorA after Vaccination with a Meningococcal B Outer Membrane Vesicle Vaccine Clementien L. Vermont, Harry H. van Dijken, Anneke Kuipers, Infection and Immunity VaccinationVaccinologyCross-protectionMucosal VaccinationVaccine Development	2003	44

Page 1